Cord Tissue Stem Cell Processing via 3D Culture and Low Oxygen
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current stem cell therapies face challenges due to suboptimal methods of isolating, culturing, and preserving stem cells and biomatrices, leading to inconsistent quality, increased rejection risks, and reduced efficacy, particularly due to the use of two-dimensional cultures, harsh processing methods, and immunological incompatibilities.
Innovation Solution
A method for processing human umbilical cord tissue to produce autologous or HLA-matched stem cell products and decellularized tissue matrices, which are cultured in three-dimensional environments with autologous serum or platelet lysate under low oxygen tension, minimizing enzymatic treatment and using gentle mechanical dissociation to preserve the natural biology and regenerative potential of stem cells.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If harsh processing methods are used to isolate and culture stem cells, then productivity is improved, but the stem cells suffer damage leading to reduced reliability
Solution Approach 1:
The patent changes the physical and chemical parameters of the culture environment, specifically maintaining oxygen tension at physiological levels (5-20% O2) rather than atmospheric levels, and controlling pH, temperature, and nutrient composition to match in vivo conditions. This resolves the contradiction by enabling efficient isolation while preserving stem cell quality through parameter optimization rather than harsh processing.
Solution Approach 2:
The patent introduces serum-free media formulations containing specific growth factors, cytokines, and extracellular matrix components as intermediaries that facilitate stem cell isolation and culture without requiring harsh enzymatic or mechanical processing. These intermediary substances mediate between the isolation process and stem cell integrity, enabling productivity while maintaining reliability.
2Ease of operation
If two-dimensional culture methods are used, then ease of operation is improved, but the regenerative potential of stem cells deteriorates
Solution Approach 1:
The patent transitions from two-dimensional planar culture to three-dimensional culture systems that more closely mimic the in vivo microenvironment. This dimensional change enables stem cells to maintain their regenerative potential while still being cultured in controlled laboratory settings, resolving the contradiction between operational simplicity and biological functionality.
3Productivity
If allogeneic stem cells are used, then productivity is improved, but immunoreactivity increases leading to reduced reliability
Solution Approach 1:
The patent modifies the immunological parameters by using physiological oxygen tension and serum-free culture conditions that maintain stem cell immaturity and reduce immunogenicity. This enables the use of allogeneic stem cells with reduced immunoreactivity, resolving the contradiction between availability and safety.
Data Source
AI summary
Methods and products obtained from the method for isolating and culturing mixed populations of stem cells, making decellularized tissue matrix, making decellularized tissue matrix infused with said mixed populations of stem cells, and methods of stem cell therapy are provided.